Overview

* HealthWarehouse.com ( HEWA ) Q3 sales decline 7% due to slowing DTC sales and GLP-1 market shifts

* Company reports Q3 net loss of $72,000 but positive cash flow achieved

* Year-to-date sales increase 97% over prior year, reflecting strong growth

Outlook

* HealthWarehouse.com ( HEWA ) optimistic about new product launches diversifying its catalog

* Company focusing on direct-to-patient market opportunities

* HealthWarehouse.com ( HEWA ) investing in technology for efficiency and scalability

Result Drivers

* GLP-1 MARKET SHIFT - Decline in sales driven by reduced compounded GLP-1 prescription sales

* DTC SALES DECLINE - Direct-to-consumer prescription sales fell, impacting overall revenue

* CASH FLOW POSITIVE - Despite sales decline, company achieved positive cash flow and increased cash reserves

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales $8.4 mln

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)